EMTU-01 - Early morning symposium: Point of care testing (POC) in pharmacies as part of chronic disease management in community setting (Supported by Nova Biomedical)

Meeting room 2.40
Organised by Nova Biomedical

Chair(s)

Mr Marcin Pacek, Senior Medical Director, Nova Biomedical, Spain

Introduction

Attendees will be able to hear real-world examples from different countries of how point of care diagnostics can be successfully used in pharmacy setting for management of most prevalent chronic diseases.

Programme

08:00 – 08:02 Chair introduction
08:02 – 08:17 Medication optimization in kidney disease using NovaMaxPro Creatinine Meter
Prof. Ronald Castelino, Associate Professor, University of Sydney. Faculty of Medicine and Health, School of Pharmacy, Australia
08:17 – 08:32 Integrating POCT quality standards in community pharmacy diagnostic testing
Prof. Andrea Urbani, PhD. Chair of Clinical Biochemistry and Molecular Biology. Director of the Department of basic biotechnological sciences, intensivological and perioperative clinics, Catholic University of the “Sacred Heart”, Faculty of Medicine, Director of Clinical Chemistry, Biochemistry and Molecular Biology Operations(UOC), Gemelli Lab Coordinator Policlinico A. Gemelli – IRCCS, Rome, Italy
08:32 – 08:45 The importance of community pharmacy in Chronic Kidney Disease patient management. Drug dosage adjustment and Nephrotoxicity detection
Mr Marcin Pacek, Senior Medical Director, Nova Biomedical, Spain
08:45 – 08:50 Closing

Learning objectives

  • Learn about benefits point of care diagnostic technologies available for chronic disease management in pharmacy setting.
  • Learn about integration of POC testing activities in pharmacies with hospital information systems and benefits it can provide.
  • Learn about opportunities and benefits POC testing in pharmacies offers to the health care system, as well as to improving population health.

Take home messages

  • POC testing in pharmacies can improve chronic disease management in community settings.
  • Kidney function assessment using creatinine/eGFR measuring device can be very beneficial for medication optimization as well as for CKD screening in pharmacy settings.